Us Bancorp \De\ Bluebird Bio, Inc. Transaction History

Us Bancorp \De\

$75.6 Billion
Q4 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$0.85 - $1.26 $561 - $832	661 Added 49.33%	2,001 $1,000
Q1 2024 May 07, 2024	SELL	$0.91 - $1.75 $1,746 - $3,358	-1,919 Reduced 58.88%	1,340 $1,000
Q4 2023 Feb 09, 2024	BUY	$1.32 - $4.83 $2,378 - $8,703	1,802 Added 123.68%	3,259 $4,000
Q3 2023 Nov 03, 2023	SELL	$3.02 - $4.05 $18,283 - $24,518	-6,054 Reduced 80.6%	1,457 $4,000
Q2 2023 Aug 09, 2023	BUY	$2.79 - $5.03 $18,829 - $33,947	6,749 Added 885.7%	7,511 $24,000
Q1 2023 May 09, 2023	SELL	$3.14 - $8.22 $7,799 - $20,418	-2,484 Reduced 76.52%	762 $2,000
Q4 2022 Feb 13, 2023	SELL	$5.77 - $8.49 $26,957 - $39,665	-4,672 Reduced 59.0%	3,246 $22,000
Q3 2022 Oct 27, 2022	BUY	$3.75 - $7.39 $20,827 - $41,044	5,554 Added 234.94%	7,918 $50,000
Q2 2022 Aug 01, 2022	SELL	$2.94 - $5.23 $17,998 - $32,018	-6,122 Reduced 72.14%	2,364 $10,000
Q1 2022 May 11, 2022	BUY	$4.07 - $10.6 $15,657 - $40,778	3,847 Added 82.93%	8,486 $41,000
Q4 2021 Feb 11, 2022	BUY	$8.96 - $16.31 $33,465 - $60,917	3,735 Added 413.16%	4,639 $47,000
Q3 2021 Nov 10, 2021	SELL	$11.24 - $21.0 $69,710 - $130,242	-6,202 Reduced 87.28%	904 $17,000
Q2 2021 Aug 05, 2021	BUY	$18.04 - $22.09 $14,486 - $17,738	803 Added 12.74%	7,106 $227,000
Q1 2021 Apr 28, 2021	BUY	$16.59 - $33.89 $83,364 - $170,297	5,025 Added 393.19%	6,303 $190,000
Q4 2020 Feb 04, 2021	SELL	$27.5 - $37.92 $17,517 - $24,155	-637 Reduced 33.26%	1,278 $55,000
Q3 2020 Nov 10, 2020	SELL	$34.44 - $43.75 $90,818 - $115,368	-2,637 Reduced 57.93%	1,915 $103,000
Q2 2020 Aug 07, 2020	SELL	$27.12 - $45.97 $22,374 - $37,925	-825 Reduced 15.34%	4,552 $277,000
Q1 2020 May 13, 2020	BUY	$26.16 - $63.5 $65,792 - $159,702	2,515 Added 87.88%	5,377 $247,000
Q4 2019 Feb 04, 2020	SELL	$46.96 - $61.67 $57,244 - $75,175	-1,219 Reduced 29.87%	2,862 $252,000
Q3 2019 Nov 08, 2019	SELL	$59.47 - $93.1 $2,378 - $3,724	-40 Reduced 0.97%	4,081 $375,000
Q2 2019 Aug 13, 2019	SELL	$75.84 - $105.21 $151 - $210	-2 Reduced 0.05%	4,121 $524,000
Q1 2019 May 08, 2019	BUY	$64.44 - $104.11 $73,203 - $118,268	1,136 Added 38.03%	4,123 $649,000
Q4 2018 Feb 13, 2019	SELL	$59.1 - $93.26 $79,430 - $125,341	-1,344 Reduced 31.03%	2,987 $297,000
Q3 2018 Nov 01, 2018	BUY	$88.86 - $117.49 $26,035 - $34,424	293 Added 7.26%	4,331 $632,000
Q2 2018 Aug 08, 2018	BUY	$99.64 - $127.59 $99 - $127	1 Added 0.02%	4,038 $634,000
Q1 2018 May 08, 2018	BUY	$105.8 - $150.94 $423,834 - $604,665	4,006 Added 12922.58%	4,037 $689,000
Q4 2017 Feb 02, 2018	SELL	$81.25 - $130.7 $13,731 - $22,088	-169 Reduced 84.5%	31 $6,000
Q3 2017 Nov 13, 2017	BUY	$57.74 - $91.42 $11,548 - $18,284	200	200 $27,000

Others Institutions Holding BLUE

# of Institutions

Shares Held

27M

Call Options Held

191K

Put Options Held

299K

Black Rock Inc. New York, NY

15.4M
Shares

$112 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$33.9 Million
0.02% of portfolio
Colony Group LLC Boston, MA

41.9K
Shares

$304,918
0.0% of portfolio
Connacht Asset Management LP New York, NY

31.6K
Shares

$229,979
0.59% of portfolio
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL

28.7K
Shares

$208,721
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $561M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account